Take part in a global Parkinson’s carers survey

News

Author: Joe McAweaneyPublished: 18 July 2019

Prep: Cook: Serves:

The European Parkinson’s Disease Association (EPDA) is inviting carers from within the Parkinson’s community to take part in a survey aiming to shine a light on the physical, financial and emotional difficulties they face.

The research – supported by French healthcare devices company Air Liquide – will be used to inform future campaigns and create valuable tools to help carers and the wider Parkinson’s community.

Russell Patten, the secretary general of the EPDA, said: “Carers are such an important part of the Parkinson’s community – they provide the firm foundations that support their loved ones who are physically living with the condition.

“However, carers’ needs and quality of life are sadly, all too often, overlooked; this can lead to devastating and lasting effects on the individual and the wider society.”

The survey is open until 6 September 2019, and is available in English, French, German Italian, Danish, Dutch, Portuguese, Slovenian and Spanish.

For more information on caring and Parkinson’s please visit the EPDA website.

Listen to Episode Two of the Parkinson’s Life podcast, “Caring for a family member with Parkinson’s”, available on SoundCloud, iTunes and YouTube.

Parkinson’s may originate in the gut, says new study

Last Month

Next Month

Go Back

Share this story

Comments

Health & Fitness

Sign up to Nordic walking and beach fitness at Parkinson’s bootcamp

Spaces now available for summer exercise camp in Portugal

When will new Parkinson’s psychosis drug be approved outside of the US?

FDA approves drug to treat hallucinations and delusions

Ryan Reynolds in emotional plea as dad loses fight with Parkinson’s disease

Actor honours father and urges donations for Parkinson’s research

Musical therapy study to receive $20 million in funding

The National Institutes of Health (NIH) is donating US $20 million to a medical trial researching the effects of musical therapy on brain conditions, including Parkinson’s. The trial will be carried out by the Sound Health initiative, a joint partnership between the NIH and The John F Kennedy Center for the Performing Arts. The initiative was created to expand current knowledge of how listening, performing and creating music could be harnessed for health and wellness. Francis S. Collins, director of the NIH, said: “We know that the beat of a metronome can steady the gait of someone with Parkinson’s disease, for example, but we don’t fully understand how that happens. “If we can pinpoint in the brain how music therapy works through the use of imaging and biomarkers, the hope is that we can improve its effectiveness and apply it more broadly to improve the lives of millions of people.”

Researchers develop automated system to diagnose Parkinson’s

In an international study, researchers from the US, Germany and Austria have used a non-invasive MRI method to develop an automated system that can diagnose Parkinson’s. As part of the study – published in medical journal ‘The Lancet Digital Health’ – researchers worked with 1,002 patients and used an imaging method that measures how water molecules diffuse in the brain. This helped them to identify where neurodegeneration is occurring. Researchers hope this will help improve the accuracy of early Parkinson’s diagnoses – which they estimate to be around 58%. Dr David Vaillancourt, who led the study, said: “Our method may help to reduce the number of misdiagnosed cases in the future. Since these diseases require unique treatment plans and different medications, and clinical trials testing new medications require the correct diagnosis, getting it right is important for patient care.”

MJFF announces $10 million competition for Parkinson’s

The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research. As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies. The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme. Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Take part in a global Parkinson’s carers survey

News

Author: Joe McAweaneyPublished: 18 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Health & Fitness

Sign up to Nordic walking and beach fitness at Parkinson’s bootcamp

Advances

When will new Parkinson’s psychosis drug be approved outside of the US?

Perspectives

Ryan Reynolds in emotional plea as dad loses fight with Parkinson’s disease

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Take part in a global Parkinson’s carers survey

News

Author: Joe McAweaneyPublished: 18 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Health & Fitness

Sign up to Nordic walking and beach fitness at Parkinson’s bootcamp

Advances

When will new Parkinson’s psychosis drug be approved outside of the US?

Perspectives

Ryan Reynolds in emotional plea as dad loses fight with Parkinson’s disease

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Sign in